The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis
Global tuberculosis incidence has declined marginally over the past decade, and
tuberculosis remains out of control in several parts of the world including Africa and Asia …
tuberculosis remains out of control in several parts of the world including Africa and Asia …
Clinical use of whole genome sequencing for Mycobacterium tuberculosis
Drug-resistant tuberculosis (TB) remains a major challenge to global health and to
healthcare in the UK. In 2014, a total of 6,520 cases of TB were recorded in England, of …
healthcare in the UK. In 2014, a total of 6,520 cases of TB were recorded in England, of …
[HTML][HTML] MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network
The continuous flow of new research articles on MDR-TB diagnosis, treatment, prevention
and rehabilitation requires frequent update of existing guidelines. This review is aimed at …
and rehabilitation requires frequent update of existing guidelines. This review is aimed at …
Towards tuberculosis elimination: an action framework for low-incidence countries
K Lönnroth, GB Migliori, I Abubakar… - European …, 2015 - Eur Respiratory Soc
This paper describes an action framework for countries with low tuberculosis (TB) incidence
(< 100 TB cases per million population) that are striving for TB elimination. The framework …
(< 100 TB cases per million population) that are striving for TB elimination. The framework …
Consensus management recommendations for less common non-tuberculous mycobacterial pulmonary diseases
C Lange, EC Böttger, E Cambau, DE Griffith… - The Lancet Infectious …, 2022 - thelancet.com
The 2020 clinical practice guideline for the treatment of non-tuberculous mycobacterial
pulmonary disease (NTM-PD) by the American Thoracic Society, European Respiratory …
pulmonary disease (NTM-PD) by the American Thoracic Society, European Respiratory …
Treatment of tuberculosis
CR Horsburgh Jr, CE Barry III… - New England Journal of …, 2015 - Mass Medical Soc
Treatment of Tuberculosis | New England Journal of Medicine Skip to main content The New
England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology …
England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology …
Rapid determination of anti-tuberculosis drug resistance from whole-genome sequences
F Coll, R McNerney, MD Preston… - Genome medicine, 2015 - Springer
Mycobacterium tuberculosis drug resistance (DR) challenges effective tuberculosis disease
control. Current molecular tests examine limited numbers of mutations, and although whole …
control. Current molecular tests examine limited numbers of mutations, and although whole …
The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia
Despite global reductions in HIV incidence and mortality, the 15 UNAIDS-designated
countries of Eastern Europe and Central Asia (EECA) that gained independence from the …
countries of Eastern Europe and Central Asia (EECA) that gained independence from the …
Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement
J Van Ingen, T Aksamit, C Andrejak… - European …, 2018 - Eur Respiratory Soc
Nontuberculous mycobacterial pulmonary diseases (NTM-PD) are increasingly recognised
as opportunistic infections of humans. These chronic pulmonary infections have two main …
as opportunistic infections of humans. These chronic pulmonary infections have two main …
Toward a phage cocktail for tuberculosis: susceptibility and tuberculocidal action of mycobacteriophages against diverse Mycobacterium tuberculosis strains
CA Guerrero-Bustamante, RM Dedrick, RA Garlena… - MBio, 2021 - Am Soc Microbiol
The global health burden of human tuberculosis (TB) and the widespread antibiotic
resistance of its causative agent Mycobacterium tuberculosis warrant new strategies for TB …
resistance of its causative agent Mycobacterium tuberculosis warrant new strategies for TB …